Citra Borneo Utama Tbk. vs Ikapharmindo Putramas Tbk. — how do they compare? Citra Borneo Utama Tbk. trades at Rp795 (market cap 2.47T, 58.6K 24h volume), while Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 304.92B, 13.7K 24h volume). The key difference: Citra Borneo Utama Tbk. is far larger — about 8.1× Ikapharmindo Putramas Tbk.'s market cap, and Citra Borneo Utama Tbk. is more actively traded (58.6K versus 13.7K). Which is the better fit depends on your goals.
| CBUT | IKPM | |
|---|---|---|
Market Cap | 2.47T | 304.92B |
Volume | 58.6K | 13.7K |
Lot | 586 | 137 |
Turnover | 46.6M | 2.49M |
Average Price | 795.15 | 181.39 |
Value | 46.6M | 2.49M |
Indicative Equilibrium Price | 795 | — |
Indicative Equilibrium Volume | 1 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Borneo Utama Tbk (the “Company”) was established based on Notarial Deed No. 102 dated 14 March 2013 of Teguh Hendrawan, S.H., M.Kn. Notary in Pangkalan Bun. The Company commenced its commercial activities in August 2018.
Read more on CBUT →PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →